ZTS

ZOETIS INC.
Data: 2026-07-14
$74.07
Price
-1.75%
Change
$160.48
52W High
$71.47
52W Low

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Quick Stats
Jul 14, 2026

59.2

AI Score

HOLD

0.76

Volume Ratio

Aug 06, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

ZTS Stock Summary

Last updated Jul 14, 2026

ZTS is currently trading at $74.07, positioned below its 200-day moving average of $114.9, suggesting bearish momentum. The stock has a 52-week range of $71.47 to $160.48.

Technical Analysis: The 50-day moving average stands at $80.5, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.605, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.194, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ZTS at 59.2/100 with a HOLD recommendation.

ZTS (ZOETIS INC.) Indicators

Last updated Jul 14, 2026

Indicator Value
RSI(14) 38.605
CMF (20) -0.194
ROC (10) 1.119
ADX (14) 30.98
Indicator Value
MACD (12,26,9) -2.2
AROONOSC (14) -21.429
WILLAMS %R (14) -69.176
MFI (14) 43.213
ZTS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ZTS Price vs Max Options Open Interest
ZTS Max Change In Options Open Interest

ZTS Options - Sort by Max open Interest (near term)

14th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZTS Daily Out of Money Options - Sort by Max open Interest (near term)

14th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZTS Daily In the Money Options - Sort by Max open Interest (near term)

14th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ZTS Most Active Options by Volume(near term)

14th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

ZOETIS INC. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ZTS Moving Averages Analysis

ZTS (ZOETIS INC.) Simple Moving Averages

Moving Averages are last updated Jul 14, 2026

Days MA
10 74.6
20 75.97
30 77.1
50 80.5
100 100.31
200 114.9

ZTS Fundamental Analysis

P/E (Forward) 11.0497
P/E (Trailing) 12.3869
Market Cap ($) 31.7 billion
Earnings/Share ($) 6.1
Net Proft Margin (%) 0.2804
Dividend/Share ($) 2.03
EPS Estimate Current Year ($) 6.869
EPS Estimate Next Year ($) 7.3963
WallStreet Target Price ($) 115.6471
Most Recent Quarter